Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Association of erectile dysfunction with all-cause and cardiovascular mortality in US men: findings from NHANES 2001–2004 with 16-year follow-up

Abstract

Erectile dysfunction (ED) is a common condition in men; however, evidence of its association with mortality is limited. We examined the association between ED and long-term all-cause and cardiovascular (CV) mortality in a nationally representative cohort of adult men. This prospective cohort study included data from men aged 20 years and older from the 2001–2004 National Health and Nutrition Examination Survey linked to National Death Index records through December 31, 2019. ED was defined as reporting sometimes or never being able to achieve or maintain an erection adequate for satisfactory intercourse. Primary outcomes were the associations of ED with all-cause and  CV mortality, evaluated using survey-weighted Cox proportional hazards regression models. Among 4 110 men followed for a median of 16.3 years, 1 226 deaths (419 CV deaths) occurred. In fully adjusted models, ED was independently associated with an increased risk of all-cause (HR, 1.45; 95% CI, 1.20–1.75) and CV (HR, 1.57; 95% CI, 1.12–2.19) mortality. The magnitude of these associations was similar to those observed for other CV risk factors such as diabetes mellitus, hypertension, and stroke. These findings suggest the need to broaden clinical perspectives on ED beyond sexual health to recognize its significance as a marker of mortality risk.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Selection of analytic sample from NHANES 2001–2004 participants.
Fig. 2: Association of erectile dysfunction with all-cause and cardiovascular mortality in US men aged 20 years and older.
Fig. 3: Adjusted cumulative incidence of all-cause mortality by erectile dysfunction status.
Fig. 4: Adjusted cumulative incidence of cardiovascular mortality by erectile dysfunction status.

Similar content being viewed by others

Data availability

The data from this study will not be shared. Data from the 2001–2004 National Health and Nutrition Examination Survey (https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2001; https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2003) and National Death Index records through December 31, 2019 (https://www.cdc.gov/nchs/linked-data/mortality-files/index.html) are publicly available.

References

  1. National Institutes of Health. NIH consensus conference. impotence. NIH consensus development panel on impotence. JAMA. 1993;270:83–90.

    Article  Google Scholar 

  2. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84:50–56.

    Article  PubMed  CAS  Google Scholar 

  3. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res. 2000;12:305–11.

    Article  PubMed  CAS  Google Scholar 

  4. Pinnock CB, Stapleton AM, Marshall VR. Erectile dysfunction in the community: a prevalence study. Med J Aust. 1999;171:353–7.

    Article  PubMed  CAS  Google Scholar 

  5. Nicolosi A, Glasser DB, Kim SC, Marumo K, Laumann EO. Group GI. sexual behaviour and dysfunction and help-seeking patterns in adults aged 40-80 years in the urban population of Asian countries. BJU Int. 2005;95:609–14.

    Article  PubMed  Google Scholar 

  6. Nicolosi A, Moreira ED Jr., Shirai M, Bin Mohd Tambi MI, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology. 2003;61:201–6.

    Article  PubMed  Google Scholar 

  7. Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200:633–41.

    Article  PubMed  Google Scholar 

  8. Elterman DS, Bhattacharyya SK, Mafilios M, Woodward E, Nitschelm K, Burnett AL. The quality of life and economic burden of erectile dysfunction. Res Rep Urol. 2021;13:79–86.

    PubMed  PubMed Central  Google Scholar 

  9. Banks E, Joshy G, Abhayaratna WP, Kritharides L, Macdonald PS, Korda RJ, et al. Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study. PLoS Med. 2013;10:e1001372.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Batty GD, Li Q, Czernichow S, Neal B, Zoungas S, Huxley R, et al. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (action in diabetes and vascular disease: preterax and diamicron modified-release controlled evaluation) trial. J Am Coll Cardiol. 2010;56:1908–13.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Gazzaruso C, Solerte SB, Pujia A, Coppola A, Vezzoli M, Salvucci F, et al. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol. 2008;51:2040–4.

    Article  PubMed  Google Scholar 

  12. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005;294:2996–3002.

    Article  PubMed  CAS  Google Scholar 

  13. Montorsi P, Ravagnani PM, Galli S, Rotatori F, Briganti A, Salonia A, et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol. 2005;96:19M–23M.

    Article  PubMed  Google Scholar 

  14. Fan Y, Hu B, Man C, Cui F. Erectile dysfunction and risk of cardiovascular and all-cause mortality in the general population: a meta-analysis of cohort studies. World J Urol. 2018;36:1681–9.

    Article  PubMed  Google Scholar 

  15. Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, Aznaouridis KA, Stefanadis CI. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circ Cardiovasc Qual Outcomes. 2013;6:99–109.

    Article  PubMed  Google Scholar 

  16. Loprinzi PD, Nooe A. Erectile dysfunction and mortality in a national prospective cohort study. J Sex Med. 2015;12:2130–3.

    Article  PubMed  Google Scholar 

  17. Selvin E, Wang D, Tang O, Fang M, Christenson RH, McEvoy JW. Elevated cardiac biomarkers, erectile dysfunction, and mortality in U.S. Men: NHANES 2001–2004. JACC Adv. 2023;2:100380.

    Article  PubMed  PubMed Central  Google Scholar 

  18. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–7.

    Article  Google Scholar 

  19. Centers for Disease Control and Prevention. About NHANES.2024. https://www.cdc.gov/nchs/nhanes/about/. Accessed date: October 18, 2024.

  20. O’Donnell AB, Araujo AB, Goldstein I, McKinlay JB. The validity of a single-question self-report of erectile dysfunction. results from the massachusetts male aging study. J Gen Intern Med. 2005;20:515–9.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Centers for Disease Control and Prevention. Public-use linked mortality files. 2024. https://ftp.cdc.gov/pub/Health_Statistics/NCHS/datalinkage/linked_mortality/. Accessed date: October 18, 2024.

  22. Centers for Disease Control and Prevention. The linkage of National Center for Health Statistics survey data to the National Death Index – 2019 Linked Mortality File (LMF): Linkage methodology and analytic considerations. 2024. https://www.cdc.gov/nchs/data/datalinkage/2019NDI-Linkage-Methods-and-Analytic-Considerations-508.pdf. Accessed date: October 18, 2024.

  23. De Leonardis F, Colalillo G, Finazzi Agro E, Miano R, Fuschi A, Asimakopoulos AD. endothelial dysfunction, erectile deficit and cardiovascular disease: an overview of the pathogenetic links. Biomedicines. 2022;10:1848.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Osondu CU, Vo B, Oni ET, Blaha MJ, Veledar E, Feldman T, et al. The relationship of erectile dysfunction and subclinical cardiovascular disease: A systematic review and meta-analysis. Vasc Med. 2018;23:9–20.

    Article  PubMed  Google Scholar 

  25. Allen MS, Wood AM, Sheffield D. The psychology of erectile dysfunction. Curr Directions Psychological Sci. 2023;32:487–93.

    Article  Google Scholar 

  26. Rasmussen S, Balasubramaniam K, Jarbol DE, Sondergaard J, Haastrup PF. Socioeconomic status and barriers for contacting the general practitioner when bothered by erectile dysfunction: a population-based cross-sectional study. BMC Fam Pract. 2020;21:166.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Antonio L, Wu FCW, Moors H, Mathei C, Huhtaniemi IT, Rastrelli G, et al. Erectile dysfunction predicts mortality in middle-aged and older men independent of their sex steroid status. Age Ageing. 2022;51:afac094.

    Article  PubMed  Google Scholar 

  28. Araujo AB, Travison TG, Ganz P, Chiu GR, Kupelian V, Rosen RC, et al. Erectile dysfunction and mortality. J Sex Med. 2009;6:2445–54.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Chew KK, Gibson N, Sanfilippo F, Stuckey B, Bremner A. Cardiovascular mortality in men with erectile dysfunction: increased risk but not inevitable. J Sex Med. 2011;8:1761–71.

    Article  PubMed  Google Scholar 

  30. Chung RY, Chan D, Woo J, Kwok T, Leung JC, Lai FT, et al. Erectile dysfunction is associated with subsequent cardiovascular and respiratory mortality in cohort of 1436 Chinese elderly men. J Sex Med. 2015;12:1568–76.

    Article  PubMed  Google Scholar 

  31. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596–e646.

    PubMed  PubMed Central  Google Scholar 

  32. US Department of Health and Human Services. Healthy People 2030: Browse objectives by topic. 2025. https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives. Accessed date: March 20, 2025.

  33. Horasanli K, Boylu U, Kendirci M, Miroglu C. Do lifestyle changes work for improving erectile dysfunction? Asian J Androl. 2008;10:28–35.

    Article  PubMed  CAS  Google Scholar 

  34. Ebner B, Ebner A, Reetz A, Bohme S, Schauer A, Strasser RH, et al. Pharmacological postconditioning by bolus injection of phosphodiesterase-5 inhibitors vardenafil and sildenafil. Mol Cell Biochem. 2013;379:43–49.

    Article  PubMed  CAS  Google Scholar 

  35. Ockaili R, Salloum F, Hawkins J, Kukreja RC. Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. Am J Physiol Heart Circ Physiol. 2002;283:H1263–1269.

    Article  PubMed  CAS  Google Scholar 

  36. Sesti C, Florio V, Johnson EG, Kloner RA. The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size. Int J Impot Res. 2007;19:55–61.

    Article  PubMed  CAS  Google Scholar 

  37. Salloum FN, Chau VQ, Hoke NN, Kukreja RC. Tadalafil prevents acute heart failure with reduced ejection fraction in mice. Cardiovasc Drugs Ther. 2014;28:493–500.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Andersson DP, Trolle Lagerros Y, Grotta A, Bellocco R, Lehtihet M, Holzmann MJ. Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction. Heart. 2017;103:1264–70.

    Article  PubMed  Google Scholar 

  39. Soulaidopoulos S, Terentes-Printzios D, Ioakeimidis N, Tsioufis KP, Vlachopoulos C. Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2024;10:403–12.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Andersson DP, Landucci L, Lagerros YT, Grotta A, Bellocco R, Lehtihet M, et al. Association of phosphodiesterase-5 inhibitors versus alprostadil with survival in men with coronary artery disease. J Am Coll Cardiol. 2021;77:1535–50.

    Article  PubMed  CAS  Google Scholar 

  41. Jehle DVK, Sunesra R, Uddin H, Paul KK, Joglar AA, Michler OD, et al. Benefits of tadalafil and sildenafil on mortality, cardiovascular disease, and dementia. Am J Med. 2025;138:441–8.e443.

    Article  PubMed  CAS  Google Scholar 

  42. Baldwin K, Ginsberg P, Harkaway RC. Under-reporting of erectile dysfunction among men with unrelated urologic conditions. Int J Impot Res. 2003;15:87–89.

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

Boston Scientific supported this study. The sponsor was involved in the study design, interpretation of the data, review and approval of the manuscript, and decision to submit the manuscript for publication. The sponsor was not involved in the analysis of the data or drafting of the manuscript.

Author information

Authors and Affiliations

Authors

Contributions

L.M. conducted the analysis and drafted the manuscript. S.B., S.R., and D.P. critically reviewed and edited the manuscript. S.B. supervised the project administration. All authors reviewed and approved the final version of the manuscript. L.M. had primary responsibility for the final content.

Corresponding author

Correspondence to Larry E. Miller.

Ethics declarations

Competing interests

S.B. and S.R. report employment with Boston Scientific. L.M. reports consultancy with Boston Scientific. D.P. reports receiving a grant from the Biomedical Laboratory Research & Development Service (BLRD) of the US Department of Veterans Affairs, unrelated to this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhattacharyya, S., Miller, L.E., Rojanasarot, S. et al. Association of erectile dysfunction with all-cause and cardiovascular mortality in US men: findings from NHANES 2001–2004 with 16-year follow-up. Int J Impot Res (2025). https://doi.org/10.1038/s41443-025-01218-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s41443-025-01218-z

Search

Quick links